China’s Home-Grown Oral COVID Antiviral Eyes Wider Population

Simcere Kicks Off Phase I

 
• By Dexter Jie Yan
  
clinical trial progress
SIM0417 China’s first home-grown oral 3CL protease inhibitor for COVID-19 to reach trials • Source: Alamy

More from China

More from Focus On Asia